New real-world evidence on the MSDA Test published in The Multiple Sclerosis Journal – ET&C. Read the press release.

News & Blog

Catch the latest

Recent Announcements & Press

February 24, 2022

ACTRIMS 2022 | A multivariate proteomic assay for disease activity assessments in MS – VJ Neurology

October 21, 2021

Female Founders: Melinda Thomas of Octave Bioscience On The Five Things You Need To Thrive and Succeed as a Woman Founder – Authority Magazine

October 11, 2021

Octave Bioscience Announces Strategic Investment from Merck Global Health Innovation Fund

Octave Note

Media Library